Roivant Sciences (ROIV) FCF Margin (2020 - 2025)
Roivant Sciences (ROIV) posted FCF Margin of 10339.36% for Q4 2025, up 16.06% on a QoQ basis from 12317.76% in Q3 2025, and down 721747.0% year-over-year from N/an in Q4 2024.
Roivant Sciences (ROIV) FCF Margin (2020 - 2025) Analysis & Trends
Roivant Sciences' FCF Margin history runs 6 years deep, the most recent figure standing at 10339.36% for Q4 2025.
- Quarterly FCF Margin fell 721747.0% year-over-year to 10339.36% in Q4 2025, while the trailing twelve-month figure through Dec 2025 was 3214.73% (down 125038.0% YoY) and the FY2026 annual result came in at 9173.91%, down 626870.0% from the prior year.
- FCF Margin was 10339.36% for Q4 2025 at Roivant Sciences, up from 12317.76% in the prior quarter.
- Across five years, FCF Margin topped out at 881.94% in Q3 2021 and bottomed at 12317.76% in Q3 2025.
- A 5-year average of 4438.09% and a median of 2776.53% in 2023 frame the typical range for FCF Margin.
- Annual changes were most pronounced in 2021 — FCF Margin jumped 521784 bps — and 2025, when it tumbled 721747 bps.
- Roivant Sciences' FCF Margin stood at 1175.42% in 2021, then tumbled by 69 bps to 1992.02% in 2022, then tumbled by 39 bps to 2776.53% in 2023, then retreated by 12 bps to 3121.88% in 2024, then sank by 231 bps to 10339.36% in 2025.
- Business Quant data shows ROIV's FCF Margin at 10339.36% in Q4 2025, 12317.76% in Q3 2025, and 9604.52% in Q2 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | FCF Margin (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - | - |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn | 10.45% |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - | - |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn | 43.35% |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn | 23.53% |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn | - |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - | - |
| 10 | Roivant Sciences | 24.35 Bn | 25.12 Bn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | -10,339.36% |
| Sep 30, 2025 | -12,317.76% |
| Jun 30, 2025 | -9,604.52% |
| Dec 31, 2024 | -3,121.88% |
| Sep 30, 2024 | -5,984.40% |
| Jun 30, 2024 | -2,425.46% |
| Dec 31, 2023 | -2,776.53% |
| Sep 30, 2023 | -5,392.05% |
| Jun 30, 2023 | -1,157.67% |
| Dec 31, 2022 | -1,992.02% |
| Sep 30, 2022 | -1,537.79% |
| Jun 30, 2022 | -6,009.28% |
| Dec 31, 2021 | -1,175.42% |
| Sep 30, 2021 | -881.94% |
| Jun 30, 2021 | -1,855.32% |
| Dec 31, 2020 | -3,146.45% |
| Jun 30, 2020 | -7,073.16% |